Position in VTRS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$19,103
+$8,674 QoQ
Shares Held
1,203
+55.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#705
of 1,016 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ELEVATION WEALTH PARTNERS, LLC holds $106,725 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
51 | $27,633 | |
| 2 | VTRS |
Viatris Inc
This page
|
1,203 | $19,103 | |
| 3 | ZTS |
Zoetis Inc.
|
192 | $13,797 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
693 | $11,108 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
628 | $9,099 | |
| 6 | HLN |
Haleon plc
|
924 | $8,620 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
55 | $6,101 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
135 | $4,573 |
All Filings in VTRS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,103 | 1,203 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $10,429 | 772 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $9,287 | 746 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $742 | 75 | Shares | Sole | 2025-10-14 | |
| 2023-12-31 | $7,732 | 714 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $7,040 | 714 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $7,065 | 708 | Shares | Sole | 2023-07-06 | |
| 2023-03-31 | $6,762 | 703 | Shares | Sole | 2023-05-04 | |
| No filing history on record for this holder in this stock. | ||||||